Suppr超能文献

铁死亡及其与2019冠状病毒病(COVID-19)相互作用的可视化分析

Visual analysis on ferroptosis and its cross-talk to coronavirus disease 2019 (COVID-19).

作者信息

Zhou Junda, Ni Wenjia, Zhang Xianqin, Yang Meng, Liu Xin, Guo Jinlin, Li Jian, Zhao Qi, Deng Hang, Lei Hanyue, Zhang Lin, Liao Hai, Jia Xu

机构信息

College of Life Science and Engineering, Southwest Jiaotong University, Chengdu, 610031, China.

Key Laboratory of Non-Coding RNA and Drug Discovery at Chengdu Medical College of Sichuan Province, School of Basic Medical Sciences, Chengdu Medical College, Chengdu, 610500, Sichuan, China.

出版信息

Heliyon. 2024 Sep 7;10(17):e37617. doi: 10.1016/j.heliyon.2024.e37617. eCollection 2024 Sep 15.

Abstract

BACKGROUND

Ferroptosis is a new type of programmed cell death. Although ferroptosis has been studied in various aspects, there has been no visual analysis of ferroptosis in coronavirus disease 2019 (COVID-19) to date. It is still a global health concern of the COVID-19 pandemic worldwide, three years after its outbreak. Yet the emergence of the mutant strain Omicron has caused a fourth wave of infections in many countries. The pathogenesis of COVID-19 is still undergoing extensive exploration, which holds paramount importance in mitigating future epidemics.

METHODS

For this study, CiteSpace 6.2 R4 software was used for bibliometric and visual atlas analysis of ferroptosis-related research, and the Genecards database was used to mine ferroptosis and COVID-19-related genes.

RESULTS

We found increasing studies about ferroptosis. China and the United States have demonstrated robust scientific innovation over recent years, with extensive collaboration between their institutions and authors. Ferroptosis and COVID-19 were seen to have 13 shared genes, which may be new targets for the treatment of COVID-19 in the future. Most of the shared genes are enriched in tumor necrosis factor (TNF) pathways. The majority of those genes are up-regulated under the cellular response to oxidative stress. Genes including Tumour necrosis factor (TNF), RELA proto-oncogene (RELA), Activating transcription factor 4 (ATF4), Cytochrome -245 beta chain (CYBB), Jun proto-oncogene (JUN), Mitogen-activated protein kinase 1 (MAPK1) and Heme oxygenase 1 (HMOX1), maybe a breakthrough for ferroptosis and COVID-19. Whilst previous research has shown there to be a relationship between ferroptosis and COVID-19, the specific role of ferroptosis remained unclear. Our study aimed to analyze the research status of ferroptosis and its relationship with COVID-19, to provide a useful reference for further prevention and treatment of COVID-19. Overall, uncovering the role of ferroptosis in SARS-CoV-2 infection is important for the development of new treatment strategies for COVID-19.

摘要

背景

铁死亡是一种新型的程序性细胞死亡。尽管已经从各个方面对铁死亡进行了研究,但迄今为止,尚无关于2019冠状病毒病(COVID-19)中铁死亡的可视化分析。自COVID-19疫情爆发三年以来,它仍然是全球范围内令人担忧的公共卫生问题。然而,变异毒株奥密克戎的出现已在许多国家引发了第四波感染。COVID-19的发病机制仍在广泛探索中,这对缓解未来疫情至关重要。

方法

在本研究中,使用CiteSpace 6.2 R4软件对铁死亡相关研究进行文献计量和可视化图谱分析,并使用Genecards数据库挖掘铁死亡与COVID-19相关基因。

结果

我们发现关于铁死亡的研究日益增多。近年来,中国和美国展现出强大的科技创新能力,两国机构和作者之间开展了广泛合作。铁死亡与COVID-19有13个共享基因,这些基因可能成为未来治疗COVID-19的新靶点。大多数共享基因富集于肿瘤坏死因子(TNF)通路。这些基因中的大多数在细胞对氧化应激的反应中上调。包括肿瘤坏死因子(TNF)、RELA原癌基因(RELA)、激活转录因子4(ATF4)、细胞色素-245β链(CYBB)、原癌基因Jun(JUN)、丝裂原活化蛋白激酶1(MAPK1)和血红素加氧酶1(HMOX1)等基因,可能是铁死亡和COVID-19研究的一个突破点。虽然先前的研究表明铁死亡与COVID-19之间存在关联,但铁死亡的具体作用仍不清楚。我们的研究旨在分析铁死亡的研究现状及其与COVID-19的关系,为COVID-19的进一步防治提供有益参考。总体而言,揭示铁死亡在严重急性呼吸综合征冠状病毒2(SARS-CoV-2)感染中的作用对于开发COVID-19的新治疗策略至关重要。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/bb58/11407094/5fafb05a3818/gr1.jpg

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验